Post-approval studies (Phase 4)Not Yet RecruitingNCT06911944
What this trial is testing
Amyloid Lowering for Alzheimer's in Down's With Donanemab Investigation
Who this might be right for
Down Syndrome (DS)Down Syndrome (Trisomy 21)Alzheimer Disease+1 more
Michael Rafii, MD, PhD 60